Copyright Reports & Markets. All rights reserved.

Global Gadolinium Contrast Agent Market Research Report 2021

Buy now

1 Gadolinium Contrast Agent Market Overview

  • 1.1 Product Overview and Scope of Gadolinium Contrast Agent
  • 1.2 Gadolinium Contrast Agent Segment by Type
    • 1.2.1 Global Gadolinium Contrast Agent Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Injection Type
    • 1.2.3 Oral Type
  • 1.3 Gadolinium Contrast Agent Segment by Application
    • 1.3.1 Global Gadolinium Contrast Agent Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Research Medical Center
    • 1.3.5 Others
  • 1.4 Global Gadolinium Contrast Agent Market Size Estimates and Forecasts
    • 1.4.1 Global Gadolinium Contrast Agent Revenue 2016-2027
    • 1.4.2 Global Gadolinium Contrast Agent Sales 2016-2027
    • 1.4.3 Gadolinium Contrast Agent Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gadolinium Contrast Agent Market Competition by Manufacturers

  • 2.1 Global Gadolinium Contrast Agent Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Gadolinium Contrast Agent Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Gadolinium Contrast Agent Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Gadolinium Contrast Agent Manufacturing Sites, Area Served, Product Type
  • 2.5 Gadolinium Contrast Agent Market Competitive Situation and Trends
    • 2.5.1 Gadolinium Contrast Agent Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Gadolinium Contrast Agent Players Market Share by Revenue
    • 2.5.3 Global Gadolinium Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gadolinium Contrast Agent Retrospective Market Scenario by Region

  • 3.1 Global Gadolinium Contrast Agent Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Gadolinium Contrast Agent Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Gadolinium Contrast Agent Market Facts & Figures by Country
    • 3.3.1 North America Gadolinium Contrast Agent Sales by Country
    • 3.3.2 North America Gadolinium Contrast Agent Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Gadolinium Contrast Agent Market Facts & Figures by Country
    • 3.4.1 Europe Gadolinium Contrast Agent Sales by Country
    • 3.4.2 Europe Gadolinium Contrast Agent Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Gadolinium Contrast Agent Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Gadolinium Contrast Agent Sales by Region
    • 3.5.2 Asia Pacific Gadolinium Contrast Agent Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Gadolinium Contrast Agent Market Facts & Figures by Country
    • 3.6.1 Latin America Gadolinium Contrast Agent Sales by Country
    • 3.6.2 Latin America Gadolinium Contrast Agent Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Gadolinium Contrast Agent Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Gadolinium Contrast Agent Sales by Country
    • 3.7.2 Middle East and Africa Gadolinium Contrast Agent Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Gadolinium Contrast Agent Historic Market Analysis by Type

  • 4.1 Global Gadolinium Contrast Agent Sales Market Share by Type (2016-2021)
  • 4.2 Global Gadolinium Contrast Agent Revenue Market Share by Type (2016-2021)
  • 4.3 Global Gadolinium Contrast Agent Price by Type (2016-2021)

5 Global Gadolinium Contrast Agent Historic Market Analysis by Application

  • 5.1 Global Gadolinium Contrast Agent Sales Market Share by Application (2016-2021)
  • 5.2 Global Gadolinium Contrast Agent Revenue Market Share by Application (2016-2021)
  • 5.3 Global Gadolinium Contrast Agent Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GE
    • 6.1.1 GE Corporation Information
    • 6.1.2 GE Description and Business Overview
    • 6.1.3 GE Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GE Gadolinium Contrast Agent Product Portfolio
    • 6.1.5 GE Recent Developments/Updates
  • 6.2 Bayer
    • 6.2.1 Bayer Corporation Information
    • 6.2.2 Bayer Description and Business Overview
    • 6.2.3 Bayer Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bayer Gadolinium Contrast Agent Product Portfolio
    • 6.2.5 Bayer Recent Developments/Updates
  • 6.3 Bracco Imaging
    • 6.3.1 Bracco Imaging Corporation Information
    • 6.3.2 Bracco Imaging Description and Business Overview
    • 6.3.3 Bracco Imaging Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Bracco Imaging Gadolinium Contrast Agent Product Portfolio
    • 6.3.5 Bracco Imaging Recent Developments/Updates
  • 6.4 Guerbet Group
    • 6.4.1 Guerbet Group Corporation Information
    • 6.4.2 Guerbet Group Description and Business Overview
    • 6.4.3 Guerbet Group Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Guerbet Group Gadolinium Contrast Agent Product Portfolio
    • 6.4.5 Guerbet Group Recent Developments/Updates
  • 6.5 Liebel-Flarsheim
    • 6.5.1 Liebel-Flarsheim Corporation Information
    • 6.5.2 Liebel-Flarsheim Description and Business Overview
    • 6.5.3 Liebel-Flarsheim Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Liebel-Flarsheim Gadolinium Contrast Agent Product Portfolio
    • 6.5.5 Liebel-Flarsheim Recent Developments/Updates
  • 6.6 Lantheus
    • 6.6.1 Lantheus Corporation Information
    • 6.6.2 Lantheus Description and Business Overview
    • 6.6.3 Lantheus Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Lantheus Gadolinium Contrast Agent Product Portfolio
    • 6.6.5 Lantheus Recent Developments/Updates
  • 6.7 YRPG
    • 6.6.1 YRPG Corporation Information
    • 6.6.2 YRPG Description and Business Overview
    • 6.6.3 YRPG Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 YRPG Gadolinium Contrast Agent Product Portfolio
    • 6.7.5 YRPG Recent Developments/Updates
  • 6.8 BeiLu Pharma
    • 6.8.1 BeiLu Pharma Corporation Information
    • 6.8.2 BeiLu Pharma Description and Business Overview
    • 6.8.3 BeiLu Pharma Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 BeiLu Pharma Gadolinium Contrast Agent Product Portfolio
    • 6.8.5 BeiLu Pharma Recent Developments/Updates
  • 6.9 Hengrui Medicine
    • 6.9.1 Hengrui Medicine Corporation Information
    • 6.9.2 Hengrui Medicine Description and Business Overview
    • 6.9.3 Hengrui Medicine Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Hengrui Medicine Gadolinium Contrast Agent Product Portfolio
    • 6.9.5 Hengrui Medicine Recent Developments/Updates
  • 6.10 CONSUN
    • 6.10.1 CONSUN Corporation Information
    • 6.10.2 CONSUN Description and Business Overview
    • 6.10.3 CONSUN Gadolinium Contrast Agent Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 CONSUN Gadolinium Contrast Agent Product Portfolio
    • 6.10.5 CONSUN Recent Developments/Updates

7 Gadolinium Contrast Agent Manufacturing Cost Analysis

  • 7.1 Gadolinium Contrast Agent Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Gadolinium Contrast Agent
  • 7.4 Gadolinium Contrast Agent Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Gadolinium Contrast Agent Distributors List
  • 8.3 Gadolinium Contrast Agent Customers

9 Gadolinium Contrast Agent Market Dynamics

  • 9.1 Gadolinium Contrast Agent Industry Trends
  • 9.2 Gadolinium Contrast Agent Growth Drivers
  • 9.3 Gadolinium Contrast Agent Market Challenges
  • 9.4 Gadolinium Contrast Agent Market Restraints

10 Global Market Forecast

  • 10.1 Gadolinium Contrast Agent Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Gadolinium Contrast Agent by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Gadolinium Contrast Agent by Type (2022-2027)
  • 10.2 Gadolinium Contrast Agent Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Gadolinium Contrast Agent by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Gadolinium Contrast Agent by Application (2022-2027)
  • 10.3 Gadolinium Contrast Agent Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Gadolinium Contrast Agent by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Gadolinium Contrast Agent by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Injection Type
    Oral Type

    Segment by Application
    Hospitals
    Clinics
    Research Medical Center
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GE
    Bayer
    Bracco Imaging
    Guerbet Group
    Liebel-Flarsheim
    Lantheus
    YRPG
    BeiLu Pharma
    Hengrui Medicine
    CONSUN

    Buy now